Margot Lespade

Business & Profession Education

09/14/2022 | Margot Lespade | 3 min read

We asked our 2022 Power Listers about the biggest breakthrough in cannabis science in recent memory…

Research & Development Adverse effects

09/09/2022 | Margot Lespade | 4 min read

Our top picks from the month’s research, business and policy news across the cannabis industry

Business & Profession Education

08/22/2022 | Margot Lespade | 6 min read

What is the single biggest challenge facing cannabis science in 2022 – and beyond? Our 2022 Power Listers share their thoughts…

Research & Development Addiction

08/10/2022 | Margot Lespade | 6 min read

Our top picks from the month’s research, business and policy news across the cannabis industry

Business & Profession Education

08/02/2022 | Margot Lespade | 8 min read

Shawn Helmueller discusses the biggest challenge facing cannabis science, highlights up-and-comers, and shares his personal mission for the future…

Research & Development Medical research

07/18/2022 | Lauren Robertson, Margot Lespade | 6 min read

Our top picks from the month’s research, business and policy news across the cannabis industry

Testing & Processing Mycotoxin analysis

07/14/2022 | Margot Lespade

Should cannabis consumers stop complaining about the cost of the green stuff?

Research & Development Adverse effects

07/11/2022 | Margot Lespade | 3 min read

How THC’s disruptive effects on the brain’s striato-cortical networks can be countered

Business & Profession Business

07/06/2022 | Lauren Robertson, Margot Lespade | 3 min read

Our roundup of the weird and wonderful realms of cannabis news, from the dawn of a new cannabis compound, to the story of a name change like no other

Testing & Processing Cannabinoid analysis

07/01/2022 | Margot Lespade | 3 min read

Current methods of measuring THC impairment are outdated and unreliable – could CBG, cannabichromene, and tetrahydrocannabivarin hold the answer?

Content by Margot Lespade: